Compulsory Licensing under Indian Patent Law. What is a patent A patent is a grant from the government which confers on the patentee for a limited period.

Slides:



Advertisements
Similar presentations
Actions Developing in Countries Accessing the WTO System Vung Tau, February 2006 “US – Brazil Compulsory licensing.
Advertisements

Patent System in India At Asia Pacific LES Conference- Hangzhou By Rahul Vartak LES - INDIA Partner, Krishna & Saurastri Associates 16 th October, 2013.
Patent Infringement—Statute Study 10 experts. Term of Protection Article 42 The duration of an invention patent shall be twenty years, the duration of.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
Patents in Indian Fisheries Sector  Patents in Indian Fisheries Sector  Living things generally do not qualify for being granted with patents.  If it.
IP News 指導老師:李柏靜 學生:黃馨葦 M /3/26.  Citing the high cost of one of the pharmaceutical industry's expensive new cancer drugs, India's patent.
1 Is there a conflict between competition law and intellectual property rights? Edward Whitehorn Head, Competition Affairs Branch Carrie Tang Assistant.
A very short introduction to patents & access to medicines.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
LEVY AND COMPUTATION OF TAX (SEC. 9) 1. LEVIED BY CENTRAL GOVERNMENT AND COLLECTED BY STATE GOVERNMENT: The tax payable by any dealer on sales effected.
Patent Related Flexibilities in the Pharmaceutical Field
WIPO NATIONAL WORKSHOP ON NEGOTIATING TECHNOLOGY LICENSING AGREEMENTS organized by The World Intellectual Property Organization (WIPO) in cooperation with.
TRIPS, Doha and Access to Medicines: Recent Lessons CARSTEN FINK Globalization, Intellectual Property Rights and Social Equity: Challenges and Opportunities.
Patents, TRIPS, Flexibilities & Access to Medicines –Legal Perspective Lesotho Civil Society Consultation Meeting 12 August 2014.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Patent Law Presented by: Walker & Mann, LLP Walker & Mann, LLP 9421 Haven Ave., Suite 200 Rancho Cucamonga, Ca Office.
LESOTHO VALIDATION WORKSHOP 25 NOVEMBER 2014 CAILIN MORRISON RECAP – THE INTERNATIONAL CONTEXT: THE WTO, PATENTS, TRIPS FLEXIBILITIES & ACCESS TO MEDICINES.
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
EXCLUSIVE MARKETING RIGHTS & MAIL-BOX APPLICATIONS BY Manish Kumar Prusty T. Harish.
PATENT OPPOSITION AND STRATEGY Essenese Obhan, Obhan & Associates.
Appeals in patent examination and opposition in Germany Karin Friehe Judge, Federal Patent Court, Munich, Germany.
Page 1 Implementation of the WTO Decision on TRIPS and Public Health Government of Canada August 2004.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
Background of Compulsory Licensing in North America M. ANDREA RYAN IMMEDIATE PAST PRESIDENT, AIPLA ASSISTANT GENERAL COUNSEL, PATENTS WYETH/U.S.A.
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
O VERVIEW OF P UBLIC H EALTH -R ELATED TRIPS F LEXIBILITIES Sisule F. Musungu, IQsensato (
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
UNCTAD/CD-TFT 1 Basic Features of the Multilateral Systems of Patents and Regulatory Test Data Development Dimensions of Intellectual Property Rights Hanoi.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Data Protection in compliance with Article 39 of the TRIPS Agreement Draft Amendment to the Drugs Act 1976 Humaira Mufti WIPO National Seminar on Flexibilities.
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
‘Linkage’ & other TRIPS+ provisions: a public health perspective Karin Timmermans World Health Organization Seminar “Data exclusivity and patent Bangkok.
1 Patent Claim Interpretation under Art. 69 EPC – Should prosecution history be used to interpret the patent? presented at Fordham 19th Annual Conference.
Patents. WHAT IS A PATENT- Patent, under the Act, is a grant from the Government to the inventor for a limited period of time, the exclusive right to.
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
COMPULSORY LICENSING UNDER THE INDIAN COPYRIGHT ACT T.G.Agitha.
PATENTS, INTEGRATED CIRCUITS, AND INDUSTRIAL DESIGNS Presented By: Navdeep World Trade Organization.
Intellectual Property Legislation The patents Act 1970.
Identification of Abuse of dominant market position involving IPR Wang Xianlin, KoGoan Law School of Shanghai Jiaotong University Dalian,June 11,2010.
EU-China Workshop on the Chinese Patent Law 24/25 September 2008 Topic IV: Legal Consequences of Invalidity of a Patent Prof. Dr. Christian Osterrieth.
Patents Around the World: India Dr. Rajeshkumar Acharya.
1 TOPIC III - PATENT INVALIDATION PROCEDURES EU-CHINA WORKSHOP ON THE CHINESE PATENT LAW HARBIN, SEPTEMBER 2008 Dr. Gillian Davies.
Access v. Patents: We Still Can’t Get Along Srividhya Ragavan University of Oklahoma Law Center.
1 Special mechanism for the importation of pharmaceutical products under the TRIPS Agreement Carlos M. Correa.
1 Part II Major Changes in the Third Revision of the Chinese Patent Law.
International Intellectual Property Prof. Manheim Spring, 2007 Patent Compulsory Licensing Copyright © 2007.
Article 4 [Obligations of Applicant] 4.1. As a sole and exclusive owner of the Application, Applicant warrants that.
Overview of presentation
INTELECTUAL PROPERTY RIGHTS
HISTORY OF IPR.
Tech Mahindra Limited v Commissioner of Taxation
Dispute Resolution Between ICT Service Providers in Saudi Arabia
Intellectual Property Protection and Access to Medicines
ENFORCEMENT OF PATENT RIGHTS IN EUROPE The Hungarian way
Intellectual Property, Patents, Trademarks, Copyright, and Franchising
University of Ottawa - Faculty of Law
Patent law update.
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
SPCs and the unitary patent package
TORTS RELATING TO INCORPOREAL PROPERTIES
Pharma Workshop IV Patent Linkage in the USA
Acceptance of the Protocol Amending the TRIPS Agreement
Trial before court of session
THE CODE OF CRIMINAL PROCEDURE, 1973
STRUCTURE OF THE PRESENTATION
Patenting, Innovations and copyright
Judicial System in India
Dr. Achim Seiler, EU-Project” Support of Yemen’s Accession to the WTO”
Calculation of Damages in Korean Patent Litigation
Presentation transcript:

Compulsory Licensing under Indian Patent Law

What is a patent A patent is a grant from the government which confers on the patentee for a limited period of time the exclusive privilege of making, selling and using the invention for which a patent has been granted

Purpose of a Patent To enjoy the exclusive rights over the invention. To ensure commercial returns to the inventor for the time and money spend in generating a new product.

What inventions are Patentable In order to be patentable, an invention must pass three tests:- The invention must be “novel” The invention must be Non Obvious The invention must have industrial applicability

Patent protection under Indian Law The Patent Act of 1970 was passed to govern the granting of Patents under Indian Law. To make the Indian Patent Act, 1970 compliant with the Trade Related Aspects of Intellectual Property Law (TRIPS) Agreement the act was amended in the years 1999,2002 and The Patent Act of 1970 was passed to govern the granting of Patents under Indian Law. To make the Indian Patent Act, 1970 compliant with the Trade Related Aspects of Intellectual Property Law (TRIPS) Agreement the act was amended in the years 1999,2002 and 2005.

Salient Features of the Act Provides for two types of Patent:- -) Product Patent -) Process Patent Term of Patent is 20 Years Act provides for both pre and post grant opposition No product patents for substances intended for use as food, drugs and medicines including the product of chemical processes Provision for non-working as ground for compulsory licenses, licenses of right, and revocation of patents Provision for appeal to High Court on certain decisions of the Controller Provides for two types of Patent:- -) Product Patent -) Process Patent Term of Patent is 20 Years Act provides for both pre and post grant opposition No product patents for substances intended for use as food, drugs and medicines including the product of chemical processes Provision for non-working as ground for compulsory licenses, licenses of right, and revocation of patents Provision for appeal to High Court on certain decisions of the Controller

Safeguards under the Act Compulsory license to ensure availability of drugs at reasonable prices Provision to deal with public health emergency Revocation of patent in public interest and also on security considerations

Compulsory Licensing Compulsory Licensing is defined by the WTO as :- “Compulsory licensing is when a government allows someone else to produce the patented product or process without the consent of the patent owner.”

The provisions related to Compulsory License are dealt with Under Chapter XVI of the Patent Act comprising sections 84 to 92 The Patent act allows for grant of Compulsory License for the following two grounds o Abuse of Patent Right o Public Interest The provisions related to Compulsory License are dealt with Under Chapter XVI of the Patent Act comprising sections 84 to 92 The Patent act allows for grant of Compulsory License for the following two grounds o Abuse of Patent Right o Public Interest

Grounds for obtaining a compulsory license Sec. 84 lays down three grounds for grant of a compulsory license:- That the reasonable requirements of the public with respect to the patented invention have not been satisfied. That the patented invention is not available to the public at a reasonably affordable price. That the patented invention is not worked in the territory of India. Sec. 84 lays down three grounds for grant of a compulsory license:- That the reasonable requirements of the public with respect to the patented invention have not been satisfied. That the patented invention is not available to the public at a reasonably affordable price. That the patented invention is not worked in the territory of India.

Application for Obtaining a Compulsory License The Application should be made after three years of grant of Patent. The Application should be made by a “person interested” as defined by Sec 2(t) of the Indian Patents Act :- "person interested" includes a person engaged in, or in promoting, research in the same field as that to which the invention relates; The party applying for compulsory licensing must have sought to obtain a voluntary license from the patentee on reasonable terms and such efforts have not been successful within a reasonable period as per the Controller of Patents.

In Summary Application is made by person interested Having capacity to work the invention on a commercial scale Having sought to obtain a voluntary license on reasonable terms

Procedure for grant of Compulsory License After the hearing, an appeal shall lie to the appellate board from all decisions of the controller within a period of six months After the notice of opposition is filed, the controller shall fix a date for hearing of the case An opportunity shall be given to the patentee or any other person to file opposition to grant of said license. Upon receiving the application the controller determines whether a prima facie case is made out

REASONABLE REQUIREMENTS Sec 84(7) lays down the conditions under which reasonable requirements shall deemed to not have been satisfied if:- (i)The continuance/development of an existing trade/industry or the establishment of a new trade/industry is hampered/prejudiced (ii)The demand for the patented article has not been met to an adequate extent and on reasonable terms. (iii) A market for export of the patented article manufactured in India is not being supplied or developed. Sec 84(7)(a)

By imposition of conditions on license by the patentee, manufacture, use or sale of materials not protected by the patent is prejudiced Section 84(7)(b) a licence is granted under an exclusive grant back condition, such condition shall on its own constitute a situation in which the reasonable requirement of the public shall be deemed to not have been satisfied Section 84(7) (c) the patented invention is not being worked in India on a ‘commercial scale’ Section 84(7)(d) the working of the patented invention on a commercial scale in the territory of India is being prevented or hindered by the importation from abroad of the patented article Section 84(7)(e)

Invention is not reasonably priced The patentee must make invention available to the public at a reasonable price. What is reasonable price depends upon the facts and circumstances of each case. If the price charged is an ‘excessive’ one, it may, in certain circumstances, also amount to an ‘abuse’ of a dominant position under the Competition Act (2002). “Affordable to public is required to be considered as affordable to different sections of the society.” As was held by the Controller:-

Invention is not worked in India It was held by the Controller of Patents in the case of Natco Pharma vs. Bayer Corporation Ltd that working meant “Manufacturing in India to a reasonable extent” It could be argued that the word ‘worked’ could include even importation However Sec 83(b) states that:- “Patents are not granted merely to enable patentees to enjoy monopolies for the importation of the patented article” This would negate any interpretation that one who merely imports the patented product can be said to have worked the invention in the territory of India. The High court of Bombay has however held that mere importation can be classified as working if the patentee can show that local manufacturing was not possible

Terms and Conditions for grant of Compulsory License Sec 90 lays down certain terms and conditions that the controller shall endeavour to secure for the patentee:- that the royalty if any, reserved to the patentee or other person beneficially entitled to the patent, is reasonable. that the patented invention is worked to the fullest extent by the person to whom the licence is granted and with reasonable profit to him. that the patented articles are made available to the public at reasonably affordable prices. that the licence granted is a non-exclusive licence. that the right of the licensee is non-assignable. that the licence is for the balance term of the patent. Sec 90 lays down certain terms and conditions that the controller shall endeavour to secure for the patentee:- that the royalty if any, reserved to the patentee or other person beneficially entitled to the patent, is reasonable. that the patented invention is worked to the fullest extent by the person to whom the licence is granted and with reasonable profit to him. that the patented articles are made available to the public at reasonably affordable prices. that the licence granted is a non-exclusive licence. that the right of the licensee is non-assignable. that the licence is for the balance term of the patent.

Revocation of Compulsory License According to Sec 85 of Indian Patents Act, 1970 After 2 years of grant of Compulsory License any interested person may file an application with the controller to revoke the patent on the following grounds: reasonable requirements of the public with respect to the patented invention has not been satisfied the patented invention is not available to the public at a reasonably affordable price. invention has not been worked in the territory of India The Controller if satisfied, that any of the grounds have been met may pass an order to revoke the patent. According to Sec 85 of Indian Patents Act, 1970 After 2 years of grant of Compulsory License any interested person may file an application with the controller to revoke the patent on the following grounds: reasonable requirements of the public with respect to the patented invention has not been satisfied the patented invention is not available to the public at a reasonably affordable price. invention has not been worked in the territory of India The Controller if satisfied, that any of the grounds have been met may pass an order to revoke the patent.

Compulsory licences on notifications by Central Government Section 92 of the act lays down 3 grounds for which a compulsory license may be granted by the government. They are:- National Emergency Extreme urgency Public Non Commercial Use If the government is satisfied that it is necessary that Compulsory License be granted they may make a declaration by notification in the official gazette. Subsequent to such declaration any interested party may make an application for CL and the same shall be granted as per terms and conditions set by the Controller. In this situation an Interested Party does not have to wait for three years before making said application. Section 92 of the act lays down 3 grounds for which a compulsory license may be granted by the government. They are:- National Emergency Extreme urgency Public Non Commercial Use If the government is satisfied that it is necessary that Compulsory License be granted they may make a declaration by notification in the official gazette. Subsequent to such declaration any interested party may make an application for CL and the same shall be granted as per terms and conditions set by the Controller. In this situation an Interested Party does not have to wait for three years before making said application.

Legal Precedent Natco Pharma Ltd Vs. Bayer Corporation, 2012 in front of the Controller of Patents.

Facts of the Case The Defendant is a corporation incorporated under the laws of United States of America (USA). The petitioner invented and developed its patented drug Nexavar On March 3 rd 2008, the petitioner was granted a patent by the Controller of Patents in India. The Patentee sold the drug in India at Rs2,80,000 per month. On 29 th July 2011, Natco applied to the controller for a compulsory license. Such application came about after Bayer refused to grant a voluntary license when Natco had applied for one in December, By order dated 9 March 2012 of the Controller while granting compulsory licence to Natco to manufacture and sell the patented drug also directed it to pay to the petitioner royalty at 6% of its net sales of the patented drug.

The petitioner appealed the decision in the Appellate Tribunal, where by decision dated 14 th September,2012 the tribunal upheld the decision of the controller. The decision of the Tribunal was Challenged in the High Court of Bombay by way of Writ petition under Art The High court upheld the decisions of the Controller and tribunal and dismissed said appeal

Issue 1 - Reasonable requirements of the public were not satisfied Patentee’s submission:- Bayer argued that sales made by them and CIPLA satisfied reasonable requirements of the public. The patentee argued that sales made by CIPLA should be a factor as if Bayer did succeed in getting an injunction against CIPLA in an infringement suit for Nexavar which was on-going in the Delhi High Court, the sales made by CIPLA would be deemed to be sales made by Bayer for the purpose of ascertaining damages. Thus until a decision was passed in Delhi High Court the presence of CIPLA could not be ignored. Decision The controller did not accept said argument. It was held that it is the duty of the person to whom the patent was granted to satisfy the requirements of the public. It was submitted that when the appellant had issued statements that CIPLA was an infringer and was fully pursuing a civil suit against CIPLA, it is impossible to accept its case that CIPLA’s sales should be taken into account.

Issue 2 -The drug was not available at reasonably affordable price Patentee’s Submissions:- Bayer argued that the cost of R & D and cost of manufacturing must be taken into account while determining reasonably affordable price. The contended that reasonably affordable price should be reasonable to both the patentee and the public. Decision The controller rejected the contention of the patentee and held that the reasonably affordable price is to be decided only with respect to the public and not the patentee

Issue 3 - Invention not worked in territory of India Patentee’s Submissions :- Bayer argued that ‘working in territory’ did not mean manufactured in India. Rather it meant supplied to India. They contended that the words ‘manufactured in India’ were deleted from Sec. 84(7)(a)(ii) during the amendment act of 2002 thus negating the requirement of local manufacture. Decision The court pointed out that the words ‘manufactured in India’ under Sec 84(7)(a)(ii) had referred to a separate ground for granting compulsory License i.e.- Reasonable Requirements. Thus according to the Controller the concept of ‘Manufactured in India’ was removed from the context and made a separate ground for granting CL. The Court held that the term ‘worked in the territory of India’ could not be restricted to ‘worked on a commercial scale’ and had to be interpreted as manufactured in India to a reasonable extent

Order passed by the Controller As the grounds mentioned under Sec 84 were satisfied the controller granted a compulsory License to Natco Pharma Ltd. With the following terms and conditions:- The price of the product was set at Rs per month. The Royalty was set at 6%. However in the consequent appeal royalty was increased to 7% The license is non exclusive The license is non assignable License is for manufacture and sale within territory of India only. The license is for balance term of patent only.

Fin.